A retrospective evaluation of adverse drug reactions of azathioprine in patients with autoimmunological skin diseases

Journal Title: Postępy Dermatologii i Alergologii - Year 2006, Vol 23, Issue 3

Abstract

Azathioprine (AZA) – immunosuppressive prodrug is characterized by a high interindividual variability in bioavailability and metabolism. It is used in a broad spectrum of dermatological dysimmune diseases, either as the primary drug or as adjunctive treatment. AZA undergoes non-enzymatic conversion in the liver yielding 6-mercaptopurine which afterwards is converted into cytotoxic 6-thioguanine nucleoside. It exerts immunosuppressive activity by inhibiting DNA replication during immune response. Moreover, it may also decrease proliferation of bone marrow cells which may lead to myelosuppression. Thus, the therapeutic role of AZA is often discussed because of toxicity. The study aims to characterize the toxicity profile of AZA. This study is based on retrospective examination of data taken from the hospital notes of these patients who had been treated with AZA due to dermatological dysimmune diseases. Of 294 patients evaluated, 151 were treated with AZA at a dose 50-200 mg/day. Adverse reactions (ARs) were reported in 12,6% of patients. Most of ARs occurred in patients aged between 20 and 29 years and during the first six months of treatment. Hematological toxicity occurred in 7 patients and deranged liver enzymes in 5 during the treatment with AZA. Gastrointestinal disturbances were reported by 6 patients. The pancreatitis was recognized in one patient. We conclude that azathioprine-induced toxicity should be diagnosed early and routine monitoring for its toxicity should include full blood count and liver function tests.

Authors and Affiliations

Maciej Jankowski, Elżbieta Grubska-Suchanek, Małgorzata Ruszczyńska, Jadwiga Roszkiewicz, Mirosława Szczepańska-Konkel

Keywords

Related Articles

The role of mastocytosis in anaphylaxis

The elevated basal serum tryptase, which is accompanied in 7-8% of cases of mastocytosis has been shown the important risk factor of anaphylactic reactions in patients with hymenoptera venom hypersensitivity. Mastocyto...

Diagnostic difficulties in drug adverse reactions

In the paper authors present contemporary literature data regarding diagnostic procedures in drug hypersensitivity – a significant problem, being a matter of intense research for many years. Indications for use, the meth...

Disorders of immunological balance between Th1 and Th2 cells and the role of chosen cytokines in atopic dermatitis

Atopic dermatitis (AD) is one of the most common diseases in children. This article presents current views on immunological mechanisms that take place in pathogenesis of AD. The role of disturb differentiation of T helpe...

Pachydermoperiostosis – zespół Touraine’a-Solente’a-Gole’a

Pachydermoperiostosis to rzadko występująca przerostowa osteoartropatia o nieznanej etiologii. Zmiany chorobowe dotyczą skóry i układu szkieletowego. W pracy dokonano przeglądu piśmiennictwa pod kątem występujących obj...

Download PDF file
  • EP ID EP112808
  • DOI -
  • Views 58
  • Downloads 0

How To Cite

Maciej Jankowski, Elżbieta Grubska-Suchanek, Małgorzata Ruszczyńska, Jadwiga Roszkiewicz, Mirosława Szczepańska-Konkel (2006). A retrospective evaluation of adverse drug reactions of azathioprine in patients with autoimmunological skin diseases. Postępy Dermatologii i Alergologii, 23(3), 124-129. https://europub.co.uk./articles/-A-112808